Published in PLoS One on August 11, 2017
The role of albumin in critical illness. Br J Anaesth (2000) 2.33
Comparison of the effects of albumin 5%, hydroxyethyl starch 130/0.4 6%, and Ringer's lactate on blood loss and coagulation after cardiac surgery. Br J Anaesth (2013) 2.25
Maturation of the hemostatic system during childhood. Blood (1992) 1.89
Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis. Gastroenterology (1996) 1.68
Efficacy of albumin supplementation in the surgical intensive care unit: a prospective, randomized study. Crit Care Med (1994) 1.53
Hemodilution with albumin, but not Hextend, results in hypercoagulability as assessed by Thrombelastography in rabbits: role of heparin-dependent serpins and factor VIII complex. Anesth Analg (2002) 1.43
Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation. J Thromb Haemost (2003) 1.43
Platelet function analyzer (PFA-100) offers higher sensitivity and specificity than thromboelastography (TEG) in detection of platelet dysfunction. Acta Anaesthesiol Taiwan (2009) 1.41
Changes in serum albumin and alpha 1-acid glycoprotein concentrations during pregnancy: an analysis of fetal-maternal pairs. Br J Obstet Gynaecol (1984) 1.35
Prostacyclin (prostaglandin I2, PGI2) inhibits platelet adhesion and thrombus formation on subendothelium. Blood (1979) 1.33
Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties. Br J Pharmacol (2007) 1.26
A new method for quantitative analysis of whole blood platelet interaction with extracellular matrix under flow conditions. Thromb Res (1997) 1.10
On the inhibitory effect of albumin on platelet aggregation. Thromb Res (1980) 1.06
Thrombin generation: what have we learned? Blood Rev (2012) 1.05
Prolonged length of stay and reduced functional improvement rate in malnourished stroke rehabilitation patients. Arch Phys Med Rehabil (1996) 1.03
Different effects of abciximab and cytochalasin D on clot strength in thrombelastography. J Thromb Haemost (2004) 0.98
Low tissue factor pathway inhibitor (TFPI) together with low antithrombin allows sufficient thrombin generation in neonates. J Thromb Haemost (2003) 0.96
Hypoalbuminemia is a strong predictor of 30-day all-cause mortality in acutely admitted medical patients: a prospective, observational, cohort study. PLoS One (2014) 0.93
Degradation of the endothelial glycocalyx in clinical settings: searching for the sheddases. Br J Clin Pharmacol (2015) 0.91
IP3-mediated STIM1 oligomerization requires intact mitochondrial Ca2+ uptake. J Cell Sci (2014) 0.91
Coagulation changes during presyncope and recovery. PLoS One (2012) 0.91
Serum albumin induces iNOS expression and NO production in RAW 267.4 macrophages. Br J Pharmacol (2004) 0.90
Blood coagulation dynamics in haemostasis. Hamostaseologie (2009) 0.89
Elevated thrombin-forming capacity of tissue factor-activated cord compared with adult plasma. J Thromb Haemost (2003) 0.88
Albumin-induced coagulopathy is less severe and more effectively reversed with fibrinogen concentrate than is synthetic colloid-induced coagulopathy. Scand J Clin Lab Invest (2013) 0.86
Binding of platelet activating factor to albumin. Biochim Biophys Acta (1990) 0.86
Albumin inhibits platelet-activating factor (PAF)-induced responses in platelets and macrophages: implications for the biologically active form of PAF. Br J Pharmacol (1992) 0.86
Determination of ATP and ADP Secretion from Human and Mouse Platelets by an HPLC Assay. Transfus Med Hemother (2013) 0.84
Serum albumin and risk of venous thromboembolism. Thromb Haemost (2010) 0.84
Validation of whole blood impedance aggregometry as a new diagnostic tool for HIT: results of a large Australian study. Thromb Haemost (2012) 0.82
Interactions of prostaglandin H2 and thromboxane A2 with human serum albumin. Eur J Biochem (1980) 0.82
Protein S modulates the anticoagulant action of recombinant human activated protein C: a comparison between neonates and adults. Br J Pharmacol (2005) 0.80
Induction of tissue factor activity in endothelial cells and monocytes by a modified form of albumin present in normal human plasma. Blood (1992) 0.79
Anticoagulant albumin fragments that bind to fibrinogen/fibrin: possible implications. Semin Thromb Hemost (1992) 0.79
Regulation of PGI2 activity by serum proteins: serum albumin but not high density lipoprotein is the PGI2 binding and stabilizing protein in human blood. Biochim Biophys Acta (1991) 0.78
Assessment of Hemostasis after Plasma Exchange Using Rotational Thrombelastometry (ROTEM). PLoS One (2015) 0.78
Heparin like activity of albumin. Thromb Res (1979) 0.77
The effects of haemodilution with albumin on coagulation in vitro as assessed by rotational thromboelastometry. Anaesth Intensive Care (2015) 0.77
Coagulopathy in liver disease: a balancing act. Hematology Am Soc Hematol Educ Program (2015) 0.77
Human Albumin Use in Adults in U.S. Academic Medical Centers. Crit Care Med (2017) 0.77
Protein binding and stability of norepinephrine in human blood plasma. Involvement of prealbumin, alpha 1-acid glycoprotein and albumin. Life Sci (1988) 0.77
Impact of Albumin on Coagulation Competence and Hemorrhage During Major Surgery: A Randomized Controlled Trial. Medicine (Baltimore) (2016) 0.76
Biochemical characterization of procoagulant albumin. Thromb Res (1997) 0.76
Increased shear stress- and ristocetin-induced binding of von Willebrand factor to platelets in cord compared with adult plasma. Thromb Haemost (2004) 0.76
Association Between Decreased Serum Albumin With Risk of Venous Thromboembolism and Mortality in Cancer Patients. Oncologist (2016) 0.75
Nitric oxide homeostasis as a target for drug additives to cardioplegia. Br J Pharmacol (2007) 0.75
The urea decomposition product cyanate promotes endothelial dysfunction. Kidney Int (2014) 2.81
Oxidative stress and free radicals in COPD--implications and relevance for treatment. Int J Chron Obstruct Pulmon Dis (2014) 1.04
Coagulation changes during presyncope and recovery. PLoS One (2012) 0.91
Systemic inflammation in decompensated cirrhosis: Characterization and role in acute-on-chronic liver failure. Hepatology (2016) 0.84
Bed rest does not induce hypercoagulability. Eur J Clin Invest (2015) 0.80
Functional impairment of endothelial cells by the antimycotic amphotericin B. Biochem Biophys Res Commun (2016) 0.76
The authors reply. Kidney Int (2015) 0.75
Unto the third generation: evidence for strong familial aggregation of physicians, psychologists, and psychotherapists among first-year medical and psychology students in a nationwide Austrian cohort census. BMC Med Educ (2017) 0.75
RHD Tyr311Stop encoded by a novel nonsense mutation. Transfusion (2016) 0.75
A novel ABO O allele caused by a large deletion covering two exons of the ABO gene identified in a Caucasian family showing discrepant ABO blood typing results. Transfusion (2016) 0.75
Severe case of fetal hemolytic disease caused by anti-C(w) requiring serial intrauterine transfusions complicated by pancytopenia and cholestasis. Transfusion (2015) 0.75
Novel ABO gene variants caused by missense mutations in Exon 7 leading to discrepant ABO blood typing results. Transfusion (2015) 0.75
Virtually same oxidizability of LDL but higher Lp(a) levels in arterial compared to venous plasma. Chem Phys Lipids (2014) 0.75
Prevalence of posterior vitreous detachment in glaucoma patients and controls. Acta Ophthalmol (2016) 0.75